Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Year-over-year operating income growth rate
Latest
15.04%
↑ 367% vs avg
Percentile
P96
Near historical high
Streak
1 qtr
Consecutive declineDecelerating
Average
-5.64%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 15.04% |
| Q3 2025 | 36.58% |
| Q2 2025 | 6.97% |
| Q1 2025 | -2.29% |
| Q4 2024 | 1.59% |
| Q3 2024 | 7.50% |
| Q2 2024 | -8.21% |
| Q1 2024 | 8.12% |
| Q4 2023 | -11.96% |
| Q3 2023 | -3.05% |
| Q2 2023 | -11.28% |
| Q1 2023 | 12.79% |
| Q4 2022 | -9.80% |
| Q3 2022 | -3.21% |
| Q2 2022 | 2.73% |
| Q1 2022 | 8.25% |
| Q4 2021 | -7.05% |
| Q3 2021 | -10.44% |
| Q2 2021 | -27.11% |
| Q1 2021 | -12.96% |
| Q4 2020 | -7.18% |
| Q3 2020 | -58.66% |
| Q2 2020 | -17.45% |
| Q1 2020 | 3.55% |
| Q4 2019 | -46.64% |
| Q3 2019 | -23.70% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |